— Know what they know.
Not Investment Advice
Also trades as: 0A23.L (LSE) · $vol 0M

PHR NYSE

Phreesia, Inc.
1W: +0.1% 1M: -5.8% 3M: -30.9% YTD: -46.1% 1Y: -65.6% 3Y: -71.8% 5Y: -80.8%
$8.92
+0.14 (+1.59%)
 
Weekly Expected Move ±7.7%
$7 $8 $9 $9 $10
NYSE · Healthcare · Medical - Healthcare Information Services · Alpha Radar Strong Sell · Power 37 · $551.0M mcap · 49M float · 3.91% daily turnover · Short 36% of daily vol

Revenue Segmentation

By Product / Service

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$481M +14.5% ▲
5Y CAGR: +26.4%
Gross Profit
$294M +3.4% ▲
5Y CAGR: +25.1%
Operating Income
$3M +104.5% ▲
Net Income
$2M +103.9% ▲
EPS (Diluted)
$0.04 +103.7% ▲
EBITDA
$29M +215.2% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2022FY2023FY2024FY2025FY2026
Revenue$213M$281M$356M$420M$481M
YoY Growth+43.4%+31.7%+26.8%+17.8%+14.5%
Cost of Revenue$81M$109M$124M$135M$186M
Gross Profit$132M$172M$232M$285M$294M
Gross Margin61.8%61.1%65.2%67.9%61.3%
R&D Expenses$52M$91M$112M$117M$121M
SG&A Expenses$175M$232M$227M$198M$180M
Operating Expenses$249M$348M$369M$343M$292M
Operating Income-$117M-$177M-$136M-$58M$3M
Operating Margin-54.8%-62.9%-38.3%-13.8%0.5%
Interest Expense$1M$1M$2M$2M$7M
Income Before Tax-$118M-$176M-$135M-$56M-$9M
Tax Expense$182K$483K$2M$3M$11M
Net Income-$118M-$176M-$137M-$59M$2M
Net Margin-55.4%-62.7%-38.4%-13.9%0.5%
EPS (Diluted)$-2.37$-3.36$-2.51$-1.02$0.04
EBITDA-$92M-$145M-$103M-$26M$29M
Shares Outstanding50M52M55M58M61M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms